Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19

Infection with SARS-CoV-2 leading to COVID-19 induces hyperinflammatory and hypercoagulable states, resulting in arterial and venous thromboembolic events. Deep vein thrombosis (DVT) has been well reported in COVID-19 patients. While most DVTs occur in a lower extremity, involvement of the upper extremity is uncommon. In this report, we describe the first reported patient with an upper extremity DVT recurrence secondary to COVID-19 infection.

Automated summary

Infection with SARS-CoV-2 leading to COVID-19 can cause hyperinflammatory and hypercoagulable states, resulting in arterial and venous thromboembolic events. Deep vein thrombosis (DVT) has been reported in COVID-19 patients, with most cases occurring in the lower extremities. This report describes the first documented case of upper extremity DVT recurrence secondary to COVID-19 infection.